Adelman Burt A - 16 Jun 2021 Form 3 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
Director, 10%+ Owner
Signature
/s/ Andrew Ashe, Attorney-in-Fact
Issuer symbol
VERV
Transactions as of
16 Jun 2021
Transactions value $
$0
Form type
3
Filing time
16 Jun 2021, 19:33:22 UTC
Next filing
06 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VERV Common Stock 410K 16 Jun 2021 The Burt A. Adelman 2021 GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VERV Stock Option (right to buy) 16 Jun 2021 Common Stock 43.2K $8.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on April 1, 2021 for 43,198 shares. The shares underlying the option are scheduled to vest quarterly over four years in 16 equal installments, with the first installment commencing on April 1, 2021.

Remarks:

Exhibit Index: 24.1 Power of Attorney